Ways2Capital : Forex | Indian Rupee

The Indian rupee opens flat at 64.42 per dollar. The Indian rupee opened flat at 64.42 per dollar on Monday versus 64.43 Friday.

USD / INR
64.3775 Day High 64.4200 Day Low 64.3250

EUR / INR
72.0510 Day High 72.2390 Day Low 72.0330

GBP / INR
82.1910 Day High 82.4060 Day Low 82.1480

JPY / INR
5.7977 Day High 5.8166 Day Low 5.7934

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔

Ways2Capital : Forex | Indian Rupee

The Indian rupee declined in the early trade on Friday. It has opened lower by 12 paise at 64.66 per dollar versus 64.54 Thursday.
USD / INR
64.4300 Day High 64.7350 Day Low 64.4175
EUR / INR
72.0010 Day High 72.1480 Day Low 71.9730
GBP / INR
71.9730 Day High 82.6800 Day Low 82.3020
JPY / INR
5.7931 Day High 5.8231 Day Low 5.7931
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔

Jet Airways Nearly Down 5% Post Result Of Q4

On Wednesday, Morning report Jet Airways slipped about 4.6% trade on the NSE. The report says 95% fall in net profit (consolidated) at Rs 23 crores in the last three months ended March 2017, the higher fuel price and lower fares weighed down and took a toll on its bottom line. It says that airline flew 7.02 million passengers in the January- March quarter of 2017, and had a net profit of Rs.426 crore in March ended in 2016.
They were trading at 1.7% lower at Rs.451.85, which hit a loss of Rs.438.25 and a high of Rs.457 trade in today. At present, they recouped some losses. The revenue raised over 3% to Rs.5, 728 crore in the Q4 of 2016.
7.2% where the estimated margin, but it was lower than EBITDA margin of 6.7%, it was due to increased fuel and maintenance costs. Fuel cost up by 58.6% at Rs. 1,700 on a Yoy basis, maintenance cost up by 56% at Rs.492 crore.
Naresh Goyal, Chairman of Jet Airways said the domestic and international market were both challenging in the last year. The company reduces Rs.1, 902 crores debts with despite weakening demand, especially in Gulfs and certain international markets.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔

Expecting FY18 to be Challenging year- Sun Pharma

Sun Pharma is the India’s largest drug maker, which closes to 13% and hints at a ‘single -digit decline’. US generics industry is quickly changing market dynamics, increasing competitive intensity, and its customer satisfaction and they are focusing on price.
Sun Pharma invests on R&D and also investing on funding and the clinical development of global pipeline.
In the financial year 2018 the company has hinted high tax rate, and the company’s march quarter was very low.
They are expecting that 15% US sales of FY18 for Sun Pharma and Taro portfolio. Sun Pharma is well positioned transition by the medium term.

For Quick Trial – 8962000225 ✔

or mail us here: info@ways2capital.com

or visit http://www.ways2capital.com

✆ – 0731-6626222 | Toll Free – 1800-3010-2007 

Give a Missed Call for Free Trial – 09699997717 

 

Expecting FY18 to be Challenging year- Sun Pharma

Sun Pharma is the India’s largest drug maker, which closes to 13% and hints at a ‘single -digit decline’. US generics industry is quickly changing market dynamics, increasing competitive intensity, and its customer satisfaction and they are focusing on price.
Sun Pharma invests on R&D and also investing on funding and the clinical development of global pipeline.
In the financial year 2018 the company has hinted high tax rate, and the company’s march quarter was very low.
They are expecting that 15% US sales of FY18 for Sun Pharma and Taro portfolio. Sun Pharma is well positioned transition by the medium term.

For Quick Trial – 8962000225 ✔

or mail us here: info@ways2capital.com

or visit http://www.ways2capital.com

✆ – 0731-6626222 | Toll Free – 1800-3010-2007 

Give a Missed Call for Free Trial – 09699997717 

 

Debt Woes, Reliance Communication Loss 20% in Its Q4

On Monday, The Economic Times newspaper reported that Reliance communication Ltd. doesn’t repay the loans of more than 10 banks, The company faces 20% loss in Q4 of $150 million. Anil Ambani, the billionaire posted its second straight loss in world’s biggest mobile market with number of users.
Against the Newspaper report, the company said that for waiver of certain loan covenants the confirmation is pending by the lenders, and some are continuing as non-current liabilities.
The company is planning on merging with its rival Aircel and 51% stakes selling in its radio masts business for Rs.100 billions to the Canada’s Brookfield infrastructure group and plans to repay $ 3.9 billion (Rs.250 billion) to its lenders.
Due to debt concerns, Reliance Communication falls to the maximum daily limit and Rs.20.06 a hitting a record low, Down 13% on Rs.22.40.On Monday a sell-off 2020 pounds also resumed with yields spiking 17.2%aginst 12.3% last week.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔

Ways2Capital : Indian ADRs

Indian ADRs ended mixed on Tuesday. In the IT space, Wipro was up 0.71 percent at USD 9.96 and Infosys was down 0.14 percent at USD 14.52.
In the banking space, ICICI Bank fell 1.05 percent at USD 8.48 and HDFC Bank jumped 1.42 percent at USD 81.39.
In the other sectors, Tata Motors shed 1.02 percent at USD 34.81 and Dr Reddy’s Laboratories added 0.76 percent at USD 40.85.
For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ – 0731-6626222 | Toll Free – 1800-3010-2007 ✔
Give a Missed Call for Free Trial – 09699997717 ✔